Proven MS Treatment By Dr Gary

Multiple Sclerosis Food List

Get Instant Access

1. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC. Evidence for multiple sclerosis as an infectious disease. Acta Neurol Scand Suppl 1995; 161:34-42.

2. Kurtzke JF. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1985; 6:382-427.

3. Perron H, Lalande B, Gratacap B, et al. Isolation of retrovirus from patients with multiple sclerosis. Lancet 1991; 337:862-863.

Challoner PB, Smith KT, Parker JD, et al. Plaque associated expression of human herpes virus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92:7440-7444. Sriram S, Stratton CW, Yao S, et al. Chlamydia penumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol 1999; 46:6-14.

Marie P. Sclerose en plaques et maladies infectieuses. Prog Med Paris 1884; 12:287-289, 305-307, 349-351, 365-366.

Cook SD. Multiple sclerosis. Arch Neurol 1998; 55:421-423.

McFarland DE, MacFarland HF. Multiple sclerosis. N Engl J Med 1982; 11:1246-1250. Johnson RT. The virology of demyelinating diseases. Ann Neurol 1994; 36:554-560. Rice GPA. Virus-induced demyelination in man: models for multiple sclerosis. Cuff Opin Neurol Neurosurg 1992; 5:188-194.

Raoult D, Birg M, La Scola B, Fournier P. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000; 342:620-625.

Blaser MJ. Bacteria and diseases of unknown cause. Ann Intern Med 1994; 121: 144-145.

Kurtzke JF. MS epidemiology worldwide: one view of current status. Acta Neurol Scand Suppl 1995; 161:23-33.

Cook SD. Epidemiology of multiple sclerosis: clues to etiology of amysterious disease. Neuroscientist 1996; 2:172-180.

Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911-920.

Elian M. Nightingale S, Dean G. MS among the United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies. J Neurol Neurosurg Psychiatry 1990; 50:327-332.

Alter M, Zhen-win Z, Davanipour Z, et al. Multiple sclerosis and childhood infections. Neurology 1986; 36:1386-1389.

Alvord EC, Jahnke U, Fischer EH, et al. The multiple causes of multiple sclerosis: the importance of infections in childhood. J Child Neurol 1987; 2:313-321. Haile R, Smith P, Read D, et al. A study of measles virus and canine distemper virus antibodies and of childhood infections in multiple sclerosis patients and controls. J Neurol Sci 1982; 56:1-10.

Sullivan CB, Visscher BR, Detels R. Multiple sclerosis and age of exposure to childhood diseases and animals: cases and their friends. Neurology 1984; 34:1144-1148. Poskanzer DC, Sheridan JL, Prenny LB, et al. Multiple sclerosis in the Orkney and Shetland Islands: II. The search for an exogenous aetiology. J Epidemiol Commun Health 1980; 34:240-252.

Gronning M, Riise T, Kvale G, et al. Infections in childhood and adolescence in multiple sclerosis. Neuroepidemiology 1993; 12:61-69.

Operalski EA, Visscher BR, Makngren R, Detels R. A case-control study of multiple sclerosis. Neurology 1989; 39:825-829.

Bager P, Nielsen NM, Bihrmann K, et al. Childhood infections and risk of multiple sclerosis. Brain 2004; 127:2491-2497.

Sadovnick AD, Armstrong H, Rice GPA, et al. A population based study of multiple sclerosis in twins: update. Ann Neurol 1993; 33:281-285.

Eldridge R, Hemdon CN. Multiple sclerosis in twins. N Engl J Med 1987; 318:50. Chu AB, Sever JL, Madden DL, et al. Olilgoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann Neurol 1983; 13:434-439.

Vartdal F, Vandvik B. Multiple sclerosis: electrofocused "bands" of oligoclonal CSF IgG do not carry antibody activity against measles, varicella-zoster or rotaviruses. J Neurol Sci 1992; 54:99-107.

Norrby E, Link H, Olsson JE, Panelius M, Salmi A, Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immunol 1974; 10:688-694. Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol 1978; 24:1-39.

31. Vartdal F, Vandvik B, Norrby E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 1979; 8:248-255.

32. Vandvik B, Nilsen RE, Vandal F, Norrby E. Mumps meningitis: specific and nonspecific antibody responses in the central nervous system. Acta Neurol Scand 1982; 65:468-487.

33. Yao S-Y, Sriram S. Reactivity of oligoclonal bands seen in CSF to C. pneumoniae antigens in patients with multiple sclerosis. Neurology 1999; 52(suppl 2):A559.

34. Cook SD, Dowling PC, Blumberg BM. Infection and autoimmunity in the Guillain Barre syndrome. In: Aarli JA, Behan WMH, Behan PO, eds. Clinical Neurolmmunology. London: Blackwell Scientific, 1987:225-247.

35. Kennedy PGE, Steiner L. On the possible viral aetiology of multiple sclerosis. Q J Med 1994; 87:523-528.

36. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999; 41: 2068-2074.

37. Evans CE, Horowitz MS, Hobbs MV, Oldstone MBA. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J Exp Med 1996; 184:2371-2384.

38. Rudge P. Does a retrovirally encoded superantigen cause multiple sclerosis? J Neurol Neurosurg Psychiatry 1991; 54:853-855.

39. Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162:583-591.

40. Wucherpfennig KW, Strominger JL. Molecular mimicry in T-cell mediated autoimmunity: viral peptides activate human T-cell clones specific for myelin basic protein. Cell 1995; 80:695-705.

41. Krakowka S, Cockerell G, Koestner A. Effects of canine distemper virus onlymphoid function in vitro and in vivo. Infect Immun 1975; 11:1069-1078.

42. Cerruti-Sola S, Kristensen F, Vandevelde M, Bichsel P, Kihrn U. Lymphocyte responsiveness to lectin and myelin antigens in canine distemper infection in relation to the development of demyelinating lesions. J Neuroimmunol 1983; 4:77-90.

43. Dowling PC, Cook SD. Role of infection in Guillain-Barre syndrome: laboratory confirmation of herpes viruses in 41 cases. Ann Neurol 1981; 9(suppl):44-55.

44. Cook SD, Blumberg BM, Dowling PC. Potential role of paramyxoviruses in multiple sclerosis. In: Thornton G, Booss J, eds. Neurology Clinics: Infectious Diseases of the Nervous System. Philadelphia: Saunders, 1986:303-319.

45. Boos J, Kim JH. Evidence for a viral etiology of multiple sclerosis. In: Cook SD, ed. Handbook of Multiple Sclerosis. New York: Marcel Dekker, 1990:42.

46. Adams JM, Imagawa DT. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 1962; 3:562-566.

47. Jacobson S, Flerlage ML, McFarland HF. Impaired measles virus-specific cytotoxic T-cell responses in multiple sclerosis. J Exp Med 1985; 162:839-850.

48. Haase AT, Ventura P, Gibbs CJ Jr, et al. Measles virus neucleotide sequences: detection by hybridization in situ. Science 1981; 212:672-675.

49. Crosby SL, McQuaid S, Taylor JM, et al. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genomic sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus. J Gen Virol 1989; 70:2027-2036.

50. Stevens JG, Bastone VB, Ellison GW, Myers LW. No measles virus genetic information detected in multiple sclerosis-derived brains. Ann Neurol 1979; 8:625-627.

51. Dowling PC, Blumberg BM, Kolakofsky D, et al. Measles virus nucleic acid sequences in human brain. Virus Res 1986; 5:97-107.

52. Murray R, Brown B, Brain D, Cabirac G. Detection of corona virus RNA and antigen in MS brain. Ann Neurol 1992; 31:525-533.

53. Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985; 230: 1043-1045.

Kurtzke JF. Multiple sclerosis—an overview. In: Rose FC, ed. Clinical Neuroepidemio-logy. London: Pitman Medical, 1980:170-195.

Cook SD, Cromarty JI, Tapp W, Poskanzer D, Walker JD, Dowling PC. Declining incidence of multiple sclerosis in the Orkney Islands. Neurology 1985; 35:545-551. Cook SD, Mac Donald J, Tapp W, Poskanzer D, Dowling PC. Multiple sclerosis in the Shetland Islands: An Update. Acta Neurol Scand 1988; 77:148-151. Lauer K. Multiple sclerosis in the old world: the new old map. In: Firnhaber W, Lauer L, eds. Multiple Sclerosis in Europe: An Epidemiological Update. Darmstadt: LTV Press, 1994:14-27.

Bansil S, Troiano R, Dowling PC, Cook SD. Measles vaccination does not prevent multiple sclerosis. Neuroepidemiology 1990; 9:248-254.

Ryberg B. Acute measles infection in a case of multiple sclerosis. Acta Neurol Scand 1979; 59:221-224.

Fleming JO, Zaatari FAK, Gilmore W, et al. Antigenic assessment of coronaviruses isolated from patients with multiple sclerosis. Arch Neurol 1988; 45:629-633. Stewart JN, Mounir S, Talbot PJ. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 1992; 191:502-505.

Talbot PJ, Ekande S, Cashman NR, Mounir S, Stewart J. Neurotropism of human coronavirus. In: Laude H, Vautherot JF, eds. Coronaviruses. New York: Plenum Press, 1994.

Watanabe R, Wege H, ter Meulen V. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 1983; 305:150. Tanaka R, Iwasaki Y, Koprowski H. Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. J Neurol Sci 1976; 28:121-126.

Salmi A, Zoila B, Hovi T, Reunanen M. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 1982; 32:292-295.

Sorenson O, Collins A, Flintoff W, et al. Probing for the human coronavirus OC43 in multiple sclerosis. Neurology 1986; 36:1604-1606.

Cohen JI. Epstein-Barr virus infection. N Engl J Med 2000; 343:481-492. Munch M, Hvas J, Christensen T, et al. The implications of Epstein-Barr virus in multiple sclerosis—a review. Acta Neurol Scand Suppl 1997; 169:59-64. Wolfson C. Multiple sclerosis and antecedent infections. Epidemiology 2001; 12: 298-299.

Warner HB, Carp RI. Multiple sclerosis and Epstein-Barr virus [letter]. Lancet 1981; 2:1290.

Marrie RA, Wolfson C, Stukenboom MC, et al. Multiple sclerosis and antecedent infections; a case-control study. Neurology 2000; 54:2307-2310.

Lindberg C, Andersen O, Vahlne A, et al. Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis. Neuroepidemiology 1991; 10:62-65.

Haahr S, Koch-Henriksen N, Moller-Larsen A, et al. Increased risk of multiple sclerosis after late Epstein Barr virus infection. Mult Scler 1995; 1:73-77.

Gale CR, Martyn CN. Migrant studies in multiple sclerosis. Prog Neurobiol 1995; 47:

Was this article helpful?

0 0

Post a comment